A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Clinical trial NCT07419295 · RECRUITING
Trial details
- NCT number
- NCT07419295
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2029-07-27
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.